Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 oct. 2017 01h00 HE | Source: Addex Therapeutics

Van Leeuwenhoeck Issues Initiation of Coverage Research Report on Addex Therapeutics and Estimated ADXN Share Price of CHF 11.5 per Share

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 18 October 2017...
03 oct. 2017 01h30 HE | Source: Addex Therapeutics

Addex Therapeutics ADX71441 Program Awarded $5.3 Million Grant from US National Institute on Drug Abuse to Support Human Studies for the Treatment of Cocaine Use Disorder

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 3 October 2017 -...
26 sept. 2017 01h00 HE | Source: Addex Therapeutics

Addex Therapeutics Reports First Half 2017 Operating Highlights and Financial Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 26 September...
18 sept. 2017 01h00 HE | Source: Addex Therapeutics

Addex Makes Changes to Executive Management Team

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 18 September 2017...
23 juin 2017 01h00 HE | Source: Addex Therapeutics

Addex Shareholders Approved all Board Proposals at 2017 Annual General Meeting

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Roger Mills elected to the Addex...
06 juin 2017 01h00 HE | Source: Addex Therapeutics

Addex Annual General Meeting Scheduled for 22 June 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland 6 June 2017 -...
31 mai 2017 01h00 HE | Source: Addex Therapeutics

Addex Increases Issued Share Capital and Creates Treasury Shares

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 31 May 2017 -...
09 mai 2017 01h00 HE | Source: Addex Therapeutics

Addex ADX71441 Demonstrates Preclinical Analgesic Effects

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Support Potential of ADX71441 to...
04 mai 2017 01h00 HE | Source: Addex Therapeutics

Addex ADX71441 Preclinical Results for Treatment of Alcohol Use Disorder Published in Journal of Psychopharmacology

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Study Conducted in Collaboration...
05 avr. 2017 01h00 HE | Source: Addex Therapeutics

Addex Therapeutics Provides Corporate Update and Reports 2016 Financial Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 5 April 2017 -...

Page précédente